(ECT) |
| 0 (0%) 02-27 23:28 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 61.85 |
| Resistance 1: | 52.95 |
| Pivot price: | 51.99 |
| Support 1: | 51.74 |
| Support 2: | 51.00 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sat, 21 Feb 2026
No. 15 Seton Hall Prep locks down 21st ECT title with masterpiece 3rd quarter - NJ.com
Tue, 10 Feb 2026
What 776 ECT Recipients Want You to Know - Mad in America - Science, Psychiatry and Social Justice
Tue, 10 Feb 2026
Clinical and biological markers of electroconvulsive therapy effectiveness: a narrative review - Nature
Mon, 01 Dec 2025
An international survey has reported on 25 risks of electroconvulsive therapy. - Psychology Today
Mon, 24 Nov 2025
Electroconvulsive therapy (ECT): It’s Not Just the Memory Loss - Mad in America - Science, Psychiatry and Social Justice
Wed, 19 Nov 2025
Electroconvulsive therapy may have more adverse effects than thought - The Guardian
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
